Leverone Jason A.

Insider CIK 1692747 · MGEN Chief Financial Officer · OKUR Chief Financial Officer

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
OKUR OnKure Therapeutics, Inc.	S Sale	2026-09-21	2026-09-23	302	$2.97	$897	18,500	SEC↗
OKUR OnKure Therapeutics, Inc.	S Sale	2026-09-21	2026-09-23	302	$2.97	$898	18,500	SEC↗
OKUR OnKure Therapeutics, Inc.	A Award deriv	2026-08-07	2026-08-11	5,322	—	$0	5,322	SEC↗
OKUR OnKure Therapeutics, Inc.	A Award deriv	2026-08-07	2026-08-11	5,781	—	$0	5,781	SEC↗
OKUR OnKure Therapeutics, Inc.	D To issuer deriv	2026-08-07	2026-08-11	5,781	—	$0	0	SEC↗
OKUR OnKure Therapeutics, Inc.	A Award deriv	2026-08-07	2026-08-11	50,000	—	$0	50,000	SEC↗
OKUR OnKure Therapeutics, Inc.	D To issuer deriv	2026-08-07	2026-08-11	130,611	—	$0	0	SEC↗
OKUR OnKure Therapeutics, Inc.	A Award deriv	2026-08-07	2026-08-11	130,611	—	$0	130,611	SEC↗
OKUR OnKure Therapeutics, Inc.	D To issuer deriv	2026-08-07	2026-08-11	5,322	—	$0	0	SEC↗
OKUR OnKure Therapeutics, Inc.	A Award deriv	2026-08-07	2026-08-11	130,611	—	—	130,611	SEC↗
OKUR OnKure Therapeutics, Inc.	D To issuer deriv	2026-08-07	2026-08-11	130,611	—	—	0	SEC↗
OKUR OnKure Therapeutics, Inc.	A Award deriv	2026-08-07	2026-08-11	5,322	—	—	5,322	SEC↗
OKUR OnKure Therapeutics, Inc.	D To issuer deriv	2026-08-07	2026-08-11	5,322	—	—	0	SEC↗
OKUR OnKure Therapeutics, Inc.	A Award deriv	2026-08-07	2026-08-11	5,781	—	—	5,781	SEC↗
OKUR OnKure Therapeutics, Inc.	D To issuer deriv	2026-08-07	2026-08-11	5,781	—	—	0	SEC↗
OKUR OnKure Therapeutics, Inc.	A Award deriv	2026-08-07	2026-08-11	50,000	—	$0	50,000	SEC↗
OKUR OnKure Therapeutics, Inc.	S Sale	2026-06-22	2026-06-24	303	$4.40	$1.3K	18,802	SEC↗
OKUR OnKure Therapeutics, Inc.	A Award deriv	2026-04-01	2026-04-03	110,000	—	$0	110,000	SEC↗
OKUR OnKure Therapeutics, Inc.	S Sale	2026-03-23	2026-03-24	301	$4.16	$1.3K	16,000	SEC↗
OKUR OnKure Therapeutics, Inc.	S Sale	2025-12-22	2025-12-23	302	$2.97	$897	16,301	SEC↗
OKUR OnKure Therapeutics, Inc.	S Sale	2025-09-22	2025-09-24	303	$2.62	$794	12,603	SEC↗
OKUR OnKure Therapeutics, Inc.	S Sale	2025-06-23	2025-06-25	303	$2.38	$721	12,906	SEC↗
OKUR OnKure Therapeutics, Inc.	S Sale	2025-04-07	2025-04-08	1,844	$2.67	$4.9K	13,209	SEC↗
OKUR OnKure Therapeutics, Inc.	S Sale	2025-04-04	2025-04-08	1,278	$3.33	$4.3K	15,053	SEC↗
OKUR OnKure Therapeutics, Inc.	A Award deriv	2025-01-27	2025-01-29	65,000	—	$0	65,000	SEC↗
OKUR OnKure Therapeutics, Inc.	A Award deriv	2024-10-04	2024-10-08	5,322	—	$0	5,322	SEC↗
OKUR OnKure Therapeutics, Inc.	A Award deriv	2024-10-04	2024-10-08	130,611	—	$0	130,611	SEC↗
OKUR OnKure Therapeutics, Inc.	A Award deriv	2024-10-04	2024-10-08	5,781	—	$0	5,781	SEC↗
OKUR OnKure Therapeutics, Inc.	A Award	2024-10-04	2024-10-08	16,331	—	$0	16,331	SEC↗
VRDN Viridian Therapeutics, Inc	A Award deriv	2021-01-18	2021-01-20	311,785	—	$0	311,785	SEC↗
MGEN MIRAGEN THERAPEUTICS, INC.	M Exercise deriv	2020-03-13	2020-03-17	11,249	—	$0	0	SEC↗
MGEN MIRAGEN THERAPEUTICS, INC.	M Exercise	2020-03-13	2020-03-17	11,249	$0.57	$6.4K	48,829	SEC↗
MGEN MIRAGEN THERAPEUTICS, INC.	A Award deriv	2020-02-12	2020-02-14	185,000	—	$0	185,000	SEC↗
MGEN MIRAGEN THERAPEUTICS, INC.	M Exercise deriv	2019-08-23	2019-08-23	3,093	—	$0	0	SEC↗
MGEN MIRAGEN THERAPEUTICS, INC.	M Exercise	2019-08-23	2019-08-23	3,093	$0.57	$1.8K	36,330	SEC↗
MGEN MIRAGEN THERAPEUTICS, INC.	A Award deriv	2019-02-06	2019-02-08	75,000	—	$0	75,000	SEC↗
MGEN MIRAGEN THERAPEUTICS, INC.	M Exercise deriv	2018-08-07	2018-08-09	29,530	—	$0	0	SEC↗
MGEN MIRAGEN THERAPEUTICS, INC.	M Exercise	2018-08-07	2018-08-09	29,530	$0.57	$16.8K	30,737	SEC↗
MGEN MIRAGEN THERAPEUTICS, INC.	A Award deriv	2018-01-31	2018-02-02	75,000	—	$0	75,000	SEC↗
MGEN MIRAGEN THERAPEUTICS, INC.	A Award deriv	2017-02-16	2017-02-16	77,500	—	$0	77,500	SEC↗